Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
20Feb2026
  • Home
  • About
  • News
  • Subscribe
20Feb2026
Cost Curve NewsCost Curve News
Cost Curve News

There Are Eye-Popping New 340B Numbers Out from Drug Channels

I would love to write pages and pages about the trove of 340B data that Adam Fein dropped over the weekend, but if you really care about the issue, you
costcurvenews
2 years ago
Keep Reading
Cost Curve News

Industry and Patient Groups Agree: Time Drive Attention to ‘Smoothing’

The “smoothing” provision is the most important part of the IRA that no one has heard of (I mean, you all have heard of it, but I don’t consider any
costcurvenews
2 years ago
Keep Reading
535455

Latest Posts

Moving to MFN Means QALYs — Long Rejected by U.S. Policymakers as Discriminatory — Would Be Used to Set Prices

February 19, 2026

Oz Continues to Press for MFN ‘Codification’ at PhRMA Event

February 18, 2026

Going Deeper on Another ‘Pharm-to-Conference-Table’ Obesity Offering

February 17, 2026

The Government Is Looking for 340B Rebate Model Feedback As It Resurrects Rulemaking

February 13, 2026

Big Pharma Companies Won Concessions via Dealmaking With Trump. But What Happens to Everyone Else?

February 12, 2026

Popular

Moving to MFN Means QALYs — Long Rejected by U.S. Policymakers as Discriminatory — Would Be Used to Set Prices

Oz Continues to Press for MFN ‘Codification’ at PhRMA Event

Going Deeper on Another ‘Pharm-to-Conference-Table’ Obesity Offering

The Government Is Looking for 340B Rebate Model Feedback As It Resurrects Rulemaking

Big Pharma Companies Won Concessions via Dealmaking With Trump. But What Happens to Everyone Else?

Pfizer Cut the Price of Certain Forms of Ibrance, Its Blockbuster Breast Cancer Med

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (3,324)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (2,604)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (2,161)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,985)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,953)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Moving to MFN Means QALYs — Long Rejected by U.S. Policymakers as Discriminatory — Would Be Used to Set Prices

February 19, 2026

Oz Continues to Press for MFN ‘Codification’ at PhRMA Event

February 18, 2026

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2026 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe